Etoposide, cytarabine, mercaptopurine ( DrugBank: Etoposide, Cytarabine, Mercaptopurine )


1 disease
IDDisease name (Link within this page)Number of trials
65Primary immunodeficiency1

65. Primary immunodeficiency


Clinical trials : 482 Drugs : 653 - (DrugBank : 119) / Drug target genes : 92 - Drug target pathways : 212
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00187057
(ClinicalTrials.gov)
September 200212/9/2005Study for Treatment of Cancer in Children With Ataxia-telangiectasiaPilot Study I for Treatment of Cancer in Children With Ataxia-TelangiectasiaAtaxia-TelangiectasiaDrug: vinblastine, vincristine, prednisone, daunorubicin;Drug: doxorubicin, methotrexate, cyclophosphamide, L-asparaginase;Drug: etoposide, cytarabine, mercaptopurine;Drug: dexamethasone, procarbazine;Procedure: chemotherapy, intrathecal chemotherapy, steroid therapySt. Jude Children's Research HospitalChildren's Hospital of Philadelphia;National Cancer Institute (NCI)CompletedN/A10 YearsBoth6N/AUnited States